-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $586

Benzinga·07/13/2026 10:57:18
Listen to the news
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $495 to $586.